Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian C Marschner

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
European Journal of Endocrinology|December 25, 2024
Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk modelKristy P Robledo, Ian C Marschner, Mathis Grossmann, et al.
JCI Insight|July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary preventionKaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
The Lancet. Respiratory Medicine|August 25, 2025
Expedited transfer from the scene for refractory out-of-hospital cardiac arrest in Australia: a prospective, multicentre, parallel, open label, randomised clinical trialBrian Burns, Ian C Marschner, Hergen Buscher, et al.
BMJ Open|January 21, 2022
Transforming Obesity Prevention for CHILDren (TOPCHILD) Collaboration: protocol for a systematic review with individual participant data meta-analysis of behavioural interventions for the prevention of early childhood obesityKylie E Hunter, Brittany J Johnson, Lisa Askie, et al.
BMJ Open|January 21, 2022
Unpacking the behavioural components and delivery features of early childhood obesity prevention interventions in the TOPCHILD Collaboration: a systematic review and intervention coding protocolBrittany J Johnson, Kylie E Hunter, Rebecca K Golley, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
NEJM Evidence|February 6, 2024
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
European Journal of Endocrinology|December 25, 2024
Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk modelKristy P Robledo, Ian C Marschner, Mathis Grossmann, et al.
JCI Insight|July 12, 2019
Changes in plasma lipids predict pravastatin efficacy in secondary preventionKaushala S Jayawardana, Piyushkumar A Mundra, Corey Giles, et al.
The Lancet. Respiratory Medicine|August 25, 2025
Expedited transfer from the scene for refractory out-of-hospital cardiac arrest in Australia: a prospective, multicentre, parallel, open label, randomised clinical trialBrian Burns, Ian C Marschner, Hergen Buscher, et al.
BMJ Open|January 21, 2022
Transforming Obesity Prevention for CHILDren (TOPCHILD) Collaboration: protocol for a systematic review with individual participant data meta-analysis of behavioural interventions for the prevention of early childhood obesityKylie E Hunter, Brittany J Johnson, Lisa Askie, et al.
BMJ Open|January 21, 2022
Unpacking the behavioural components and delivery features of early childhood obesity prevention interventions in the TOPCHILD Collaboration: a systematic review and intervention coding protocolBrittany J Johnson, Kylie E Hunter, Rebecca K Golley, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
NEJM Evidence|February 6, 2024
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
Pageof 6